Article Text

Download PDFPDF
Silencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith–Wiedemann syndrome
  1. N Diaz-Meyer1,
  2. C D Day1,
  3. K Khatod1,
  4. E R Maher2,
  5. W Cooper2,
  6. W Reik3,
  7. C Junien4,
  8. G Graham5,
  9. E Algar6,
  10. V M Der Kaloustian7,
  11. M J Higgins1
  1. 1Departments of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY, USA
  2. 2Section of Medical and Molecular Genetics, Department of Paediatrics and Child Health, University of Birmingham, UK
  3. 3Laboratory of Developmental Genetics and Imprinting, Babraham Institute, Cambridge, UK
  4. 4Inserm UR383, Hopital Necker Enfants Malades, Paris, France
  5. 5Department of Genetics, Children’s Hospital of Eastern Ontario, Ottawa, Canada
  6. 6Department of Paediatrics, University of Melbourne, Victoria, Australia
  7. 7 McGill University and Department of Medical Genetics, Montreal Children’s Hospital, Montreal, Canada
  1. Correspondence to:
 M J Higgins
 Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA;


Context: Beckwith–Wiedemann syndrome (BWS) arises by several genetic and epigenetic mechanisms affecting the balance of imprinted gene expression in chromosome 11p15.5. The most frequent alteration associated with BWS is the absence of methylation at the maternal allele of KvDMR1, an intronic CpG island within the KCNQ1 gene. Targeted deletion of KvDMR1 suggests that this locus is an imprinting control region (ICR) that regulates multiple genes in 11p15.5. Cell culture based enhancer blocking assays indicate that KvDMR1 may function as a methylation modulated chromatin insulator and/or silencer.

Objective: To determine the potential consequence of loss of methylation (LOM) at KvDMR1 in the development of BWS.

Methods: The steady state levels of CDKN1C gene expression in fibroblast cells from normal individuals, and from persons with BWS who have LOM at KvDMR1, was determined by both real time quantitative polymerase chain reaction (qPCR) and ribonuclease protection assay (RPA). Methylation of the CDKN1C promoter region was assessed by Southern hybridisation using a methylation sensitive restriction endonuclease.

Results: Both qPCR and RPA clearly demonstrated a marked decrease (86–93%) in the expression level of the CDKN1C gene in cells derived from patients with BWS, who had LOM at KvDMR1. Southern analysis indicated that downregulation of CDKN1C in these patients was not associated with hypermethylation at the presumptive CDKN1C promoter.

Conclusions: An epimutation at KvDMR1, the absence of maternal methylation, causes the aberrant silencing of CDKN1C, some 180 kb away on the maternal chromosome. Similar to mutations at this locus, this silencing may give rise to BWS.

  • Beckwith–Wiedemann syndrome
  • epigenetics
  • gene silencing
  • BWS, Beckwith–Wiedemann syndrome
  • LOI, loss of imprinting
  • UPD, uniparental disomy
  • RPA, ribonuclease protection assay
  • ICR, imprinting control region
  • LOM, loss of methylation
  • RT-PCR, reverse transcription coupled polymerase chain reaction
  • qPCR, quantitative PCR

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.